178 related articles for article (PubMed ID: 37269163)
1. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
[TBL] [Abstract][Full Text] [Related]
2. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
[TBL] [Abstract][Full Text] [Related]
3. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
5. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
6. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
[TBL] [Abstract][Full Text] [Related]
7. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
8. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
9. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.
He T; Ren L; Gong M; Guo Y; Wang L; Xiao X; Wang R; Bai Z
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102009. PubMed ID: 35977662
[TBL] [Abstract][Full Text] [Related]
10. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
11. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
12. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
13. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
14. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.
Kuzu UB; Öztaş E; Turhan N; Saygili F; Suna N; Yildiz H; Kaplan M; Akpinar MY; Akdoğan M; Kaçar S; Kiliç ZM; Köksal AŞ; Ödemiş B; Kayaçetin E
Hepatol Res; 2016 Apr; 46(4):277-91. PubMed ID: 25926402
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Chalasani N; Li YJ; Dellinger A; Navarro V; Bonkovsky H; Fontana RJ; Gu J; Barnhart H; Phillips E; Lammert C; Schwantes-An TH; Nicoletti P; Kleiner DE; Hoofnagle JH;
J Hepatol; 2023 Feb; 78(2):293-300. PubMed ID: 36152763
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
Bessone F; Hernandez N; Tagle M; Arrese M; Parana R; Méndez-Sánchez N; Ridruejo E; Mendizabal M; Dagher L; Contreras F; Fassio E; Pessoa M; Brahm J; Silva M
Ann Hepatol; 2021; 24():100321. PubMed ID: 33609753
[TBL] [Abstract][Full Text] [Related]
18. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
19. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
[TBL] [Abstract][Full Text] [Related]
20. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
